- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05469295
CETIC-I (CEra Traction Improves Cervical Kyphosis -I)
A Prospective, Randomized, Single-blinded, Sham Device Controlled, Parallel Treatment Grouped, Multi-center, Exploratory Clinical Trial to Evaluate Improvement of Cervical Lordosis and Safety of CGM MB-1701 in Subjects With Cervical Kyphosis and Posterior Neck Pain.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Cervical Kyphosis are also commonly referred to as "turtle neck syndrome." It refers to the deformation of the neck bone into an inverted C-shape due to abnormalities or degenerative changes, and it is named to mean that the neck is bent like a turtle.
This device, Ceragem Master V6 (CGM MB-1701), has been certified as a combination of a personal warmer that can be used to relieve muscle pain by applying constant heat to the human body and a medical vibrator of a device that applies physical energy (vibration, shock, pressure, etc.). Also, the device got approval for use with intermittent pneumatic compression and electrically-powered orthopedics traction.
The primary purpose of this clinical trial is to confirm the temporary cervical lordosis angle improvement (height) in subjects with cervical kyphosis through the combined function of the test device.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Yangsan, South Korea
- Pusan National University Yangsan Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult male and female subjects who have voluntarily decided to participate and agreed in writing after being briefed on the characteristics of this clinical trial and medical device
- Subjects with cervical kyphosis angle between cervical lordosis 20 degrees and cervical kyphosis 5 degrees.
- BMI betweeen 18.5 and 30
- Chronic neck pain NRS 4 or higher lasting more than 3 months
Exclusion Criteria:
- Secondary spondylosis
- A tumor of the spine
- Inflammatory spondylitis
- Myelopathy
- Multiple adjacent radiculopathies and others
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CGM_MB_1701 treatment
Subjects will be treated with the study device for about 36 minutes.
|
This is a pre-approved motorized traction device.
|
|
Sham Comparator: Sham (CGM MB1701C) treament
Subjects will be treated with the Sham device for about 36 minutes.
|
It is manufactured in the same way as the test device and the operation pattern.
However, the actual effect of the massage is minimized.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean change of cervical lordosis
Time Frame: up to 16 weeks
|
Mean change of cervical lordosis using posterior tangent method of Harrison measured by cervical lateral radiography at EOT (End of Trial) compared to baseline.
|
up to 16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of cervical lordosis at 2nd interim analysis
Time Frame: up to 16 weeks
|
Change of the cervical lordosis (posterior tangent method of Harrison) measured by cervical lateral radiography at the 2nd interim visit compared to baseline.
|
up to 16 weeks
|
|
Cervical vestibular angle increase more than 10 degrees
Time Frame: up to 16 weeks
|
The fraction of subjects whose cervical vestibular angle measured by the posterior tangent method of Harrison at each time of evaluation increased by more than 10 degrees compared to the baseline
|
up to 16 weeks
|
|
Anteroposterior (T1) slope average change
Time Frame: up to 16 weeks
|
Average change in cervical anteroposterior (T1) slope measured by cervical lateral radiography at each evaluation compare to the baseline
|
up to 16 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yong Il Shin, MD, Pusan National University Yangsan Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRG_MV6_P03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kyphosis
-
Gaziantep Islam Science and Technology UniversityCompletedPostural, Thoracic Kyphosis | Postural Kyphosis | Kyphosis ThoracicTurkey
-
Cairo UniversityEnrolling by invitationKyphosis | Kyphosis Thoracic | Kyphosis Postural ThoracicEgypt
-
Riphah International UniversityRecruitingThoracic KyphosisPakistan
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompleted
-
Kahramanmaras Sutcu Imam UniversityCompletedPostural KyphosisTurkey
-
Cairo UniversityNot yet recruiting
-
New York Institute of TechnologyNot yet recruitingThoracic KyphosisUnited States
-
Riphah International UniversityCompletedCyclists | Thoracic KyphosisPakistan
-
Istanbul Medipol University HospitalCompletedBalance | Postural KyphosisTurkey
Clinical Trials on CGM MB-1701 device treatment
-
Sutter HealthWilliam Marsh Rice UniversityRecruitingDiabetes | NutritionUnited States
-
Metronom HealthMedical University of GrazUnknownDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabete MellitusAustria, Denmark
-
Baylor Research InstituteCompletedDiabetes Mellitus | Diabetes | Glucose, Low Blood | Glucose, High BloodUnited States
-
Intermountain Health Care, Inc.AbbottActive, not recruitingDiabetes Mellitus, Type 2United States
-
Beijing Tsinghua Chang Gung HospitalThe First Affiliated Hospital of Anhui Medical University; Beijing Tiantan... and other collaboratorsRecruitingComprehensive Complication IndexChina
-
Signos IncActive, not recruitingDiabetes Mellitus, Type 2 | Metabolic Syndrome | Insulin Resistance | Weight Loss | Glucose Intolerance | Central Obesity | Metabolic Glucose DisordersUnited States
-
Signos IncActive, not recruitingMetabolic Syndrome | Weight Loss | Glucose Intolerance | Pre-diabetes | Central Obesity | Metabolic Glucose DisordersUnited States
-
University of MilanCompletedGlucose Monitoring, ContinuousItaly
-
Ohio State UniversityDexCom, Inc.; The George Washington University Biostatistics CenterWithdrawnPregnancy, High Risk | Gestational Diabetes MellitusUnited States
-
University of the PacificRecruitingType 1 Diabetes | Type 2 DiabetesUnited States